A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

By J. Calabrese, C. Bowden, G. Sachs, L. Yatham, K. Behnke, O. Mehtonen, Paul Montgomery, J. Ascher, W. Paska, N. Earl and 1 more. Journal of Clinical Psychiatry, 2003

602 citations recorded by the source corpus.

Subfields: Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/5160c24d45c6f3693cbdd74dbc9f73f7b0b76b82

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. G. Malhi
2. R. Porter
3. R. Mulder
4. Paul B. Fitzgerald
5. G. Murray
6. Ajeet B Singh
7. Richard A. Bryant
8. M. Hopwood

Citations in the corpus

• Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders (2015, background): “Lamotrigine has greater efficacy in the prevention of depressive relapse but relatively modest impact on risk of manic relapse (Level I) (Bowden et al., 2003; Calabrese et al., 2003; Goodwin et al., 2004; Licht et al., 2010; Van der Loos et al., 2011).”